CN105727444B - 刺激装置 - Google Patents
刺激装置 Download PDFInfo
- Publication number
- CN105727444B CN105727444B CN201610069087.7A CN201610069087A CN105727444B CN 105727444 B CN105727444 B CN 105727444B CN 201610069087 A CN201610069087 A CN 201610069087A CN 105727444 B CN105727444 B CN 105727444B
- Authority
- CN
- China
- Prior art keywords
- microstimulator
- controller
- stimulation
- variations
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000004936 stimulating effect Effects 0.000 title abstract description 27
- 230000000638 stimulation Effects 0.000 claims abstract description 338
- 210000001508 eye Anatomy 0.000 claims description 68
- 210000004279 orbit Anatomy 0.000 claims description 33
- 238000000576 coating method Methods 0.000 claims description 18
- 239000011248 coating agent Substances 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 46
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract description 24
- 206010013774 Dry eye Diseases 0.000 abstract description 23
- 210000004561 lacrimal apparatus Anatomy 0.000 description 124
- 238000003780 insertion Methods 0.000 description 86
- 230000037431 insertion Effects 0.000 description 86
- 210000001519 tissue Anatomy 0.000 description 60
- 239000003990 capacitor Substances 0.000 description 48
- 239000012790 adhesive layer Substances 0.000 description 47
- 230000005291 magnetic effect Effects 0.000 description 43
- 210000005036 nerve Anatomy 0.000 description 38
- 230000003750 conditioning effect Effects 0.000 description 31
- 238000002224 dissection Methods 0.000 description 29
- 210000000744 eyelid Anatomy 0.000 description 24
- 239000010410 layer Substances 0.000 description 24
- 238000002560 therapeutic procedure Methods 0.000 description 19
- 230000000670 limiting effect Effects 0.000 description 18
- 210000003205 muscle Anatomy 0.000 description 18
- 239000000835 fiber Substances 0.000 description 17
- 230000005669 field effect Effects 0.000 description 15
- 239000000463 material Substances 0.000 description 14
- 208000006735 Periostitis Diseases 0.000 description 13
- 239000000853 adhesive Substances 0.000 description 13
- 230000001070 adhesive effect Effects 0.000 description 13
- 210000003460 periosteum Anatomy 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 210000003625 skull Anatomy 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000004489 tear production Effects 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 238000002604 ultrasonography Methods 0.000 description 10
- 239000011521 glass Substances 0.000 description 9
- 238000002513 implantation Methods 0.000 description 9
- 210000000795 conjunctiva Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 238000002595 magnetic resonance imaging Methods 0.000 description 6
- 210000004083 nasolacrimal duct Anatomy 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 5
- 210000004907 gland Anatomy 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 230000024883 vasodilation Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 210000004175 meibomian gland Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 210000002454 frontal bone Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 229910000457 iridium oxide Inorganic materials 0.000 description 3
- 230000007383 nerve stimulation Effects 0.000 description 3
- 210000002241 neurite Anatomy 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 2
- 241001260012 Bursa Species 0.000 description 2
- 241000083513 Punctum Species 0.000 description 2
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004397 blinking Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003302 ferromagnetic material Substances 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 229960001416 pilocarpine Drugs 0.000 description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000003670 sublingual gland Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 210000003582 temporal bone Anatomy 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 230000005641 tunneling Effects 0.000 description 2
- 210000000216 zygoma Anatomy 0.000 description 2
- 229910000859 α-Fe Inorganic materials 0.000 description 2
- 201000009487 Amblyopia Diseases 0.000 description 1
- 208000006373 Bell palsy Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000002287 Keratoconus Diseases 0.000 description 1
- 206010023642 Lacrimation decreased Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010052143 Ocular discomfort Diseases 0.000 description 1
- 206010030043 Ocular hypertension Diseases 0.000 description 1
- 208000003435 Optic Neuritis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 208000002367 Retinal Perforations Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000004350 Strabismus Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 208000013521 Visual disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000004079 adrenergic fiber Anatomy 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000000193 eyeblink Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 208000029233 macular holes Diseases 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 210000002441 meningeal artery Anatomy 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000001636 ophthalmic artery Anatomy 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 239000000734 parasympathomimetic agent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002474 sphenoid bone Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 108010019783 tear proteins Proteins 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37205—Microstimulators, e.g. implantable through a cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36046—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
- A61N1/37229—Shape or location of the implanted or external antenna
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Electromagnetism (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Electrotherapy Devices (AREA)
- Prostheses (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161473141P | 2011-04-07 | 2011-04-07 | |
| US61/473,141 | 2011-04-07 | ||
| US201161523732P | 2011-08-15 | 2011-08-15 | |
| US61/523,732 | 2011-08-15 | ||
| US13/298,042 US8918181B2 (en) | 2010-11-16 | 2011-11-16 | Systems and methods for treatment of dry eye |
| US13/298,042 | 2011-11-16 | ||
| CN201280028006.9A CN103747834B (zh) | 2011-04-07 | 2012-04-06 | 刺激装置和方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280028006.9A Division CN103747834B (zh) | 2011-04-07 | 2012-04-06 | 刺激装置和方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105727444A CN105727444A (zh) | 2016-07-06 |
| CN105727444B true CN105727444B (zh) | 2018-10-09 |
Family
ID=46969854
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610069087.7A Expired - Fee Related CN105727444B (zh) | 2011-04-07 | 2012-04-06 | 刺激装置 |
| CN201280028006.9A Expired - Fee Related CN103747834B (zh) | 2011-04-07 | 2012-04-06 | 刺激装置和方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280028006.9A Expired - Fee Related CN103747834B (zh) | 2011-04-07 | 2012-04-06 | 刺激装置和方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP2694156B8 (https=) |
| JP (5) | JP6169559B2 (https=) |
| CN (2) | CN105727444B (https=) |
| AU (3) | AU2012239966B2 (https=) |
| BR (1) | BR112013025671A2 (https=) |
| CA (1) | CA2832463A1 (https=) |
| ES (1) | ES2645204T3 (https=) |
| RU (1) | RU2013149420A (https=) |
| WO (1) | WO2012139063A2 (https=) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012068247A1 (en) | 2010-11-16 | 2012-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US9821159B2 (en) | 2010-11-16 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| US9265956B2 (en) | 2013-03-08 | 2016-02-23 | Oculeve, Inc. | Devices and methods for treating dry eye in animals |
| EP2967817B1 (en) | 2013-03-12 | 2021-03-10 | Oculeve, Inc. | Implant delivery devices and systems |
| CN105163800B (zh) | 2013-03-14 | 2019-05-14 | 微米器件有限责任公司 | 无线可植入电力接收器系统和方法 |
| NZ704579A (en) | 2013-04-19 | 2018-10-26 | Oculeve Inc | Nasal stimulation devices and methods |
| RU2547960C1 (ru) * | 2014-01-09 | 2015-04-10 | Владимир Александрович Шипилов | Способ лечения глазной поверхности при синдроме "сухого глаза" |
| WO2015130707A2 (en) * | 2014-02-25 | 2015-09-03 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
| CA2956176A1 (en) | 2014-07-25 | 2016-01-28 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| GB201414695D0 (en) * | 2014-08-19 | 2014-10-01 | Femeda Ltd | Electrostimulation related devices and methods |
| RU2707167C2 (ru) | 2014-10-22 | 2019-11-22 | Окулив, Инк. | Устройства для стимуляции и способы лечения болезни "сухого глаза" |
| WO2016065213A1 (en) | 2014-10-22 | 2016-04-28 | Oculeve, Inc. | Implantable nasal stimulator systems and methods |
| EP3209370A4 (en) | 2014-10-22 | 2018-05-30 | Oculeve, Inc. | Contact lens for increasing tear production |
| US11291847B2 (en) | 2015-06-16 | 2022-04-05 | The Regents Of The University Of Colorado, A Body Corporate | Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation |
| WO2016205107A1 (en) * | 2015-06-16 | 2016-12-22 | The Regents Of The University Of Colorado, A Body Corporate | Nasolacrimal implants and related methods for tear stimulation |
| EP3364870B1 (en) * | 2015-10-21 | 2022-09-07 | Neuspera Medical Inc. | Devices and systems for stimulation therapy |
| ITUB20154761A1 (it) * | 2015-10-29 | 2017-04-29 | Resono Ophthalmic S R L | Sistema di elettrodo e relativo dispositivo per il trattamento di patologie dell?occhio, in particolare dell?occhio secco |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| AU2017206728B2 (en) * | 2016-01-12 | 2019-11-21 | Boston Scientific Neuromodulation Corporation | Implantable device programming management |
| US10252048B2 (en) | 2016-02-19 | 2019-04-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| US11007367B2 (en) | 2016-03-16 | 2021-05-18 | Nova Oculus Canada Manufacturing Ulc | Microcurrent device for the treatment of visual disease |
| CA3022683A1 (en) | 2016-05-02 | 2017-11-09 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
| EP3522981A4 (en) * | 2016-10-04 | 2020-06-03 | The Charles Stark Draper Laboratory, Inc. | IMPLANTABLE WIRELESS MICROSTIMULATOR FOR PERIPHERAL NERVES |
| EP3525735B1 (en) * | 2016-10-14 | 2025-07-16 | Olympic Ophthalmics, Inc. | Device for stimulating tear production |
| US12233017B2 (en) | 2016-10-14 | 2025-02-25 | Olympic Ophthalmics, Inc. | Quiet handheld devices and methods for treatment of disorders |
| KR20190124698A (ko) | 2016-12-02 | 2019-11-05 | 오큘레브, 인크. | 건성안 예측 및 치료 권고를 위한 장치 및 방법 |
| CN106861041B (zh) * | 2017-02-21 | 2018-08-31 | 王乐今 | 植入式眼外肌神经肌肉刺激器及其参数设置方法 |
| CN108686301B (zh) * | 2017-04-07 | 2022-02-15 | 林伯刚 | 用于刺激视神经纤维的装置 |
| WO2018232338A1 (en) | 2017-06-16 | 2018-12-20 | AesculaTech, Inc. | Thermoresponsive polymers and uses thereof |
| WO2019034223A1 (en) * | 2017-08-18 | 2019-02-21 | Innocon Medical Aps | SYSTEM FOR ELECTRICAL STIMULATION OF NERFS |
| JP7349154B2 (ja) | 2017-08-18 | 2023-09-22 | イノコン メディカル エーピーエス | 神経の電気刺激のためのシステム |
| TWI667860B (zh) * | 2018-02-09 | 2019-08-01 | Orion Biotech Inc. | 植入式醫材遠距離無線充電強化結構 |
| CN112739410B (zh) * | 2018-09-18 | 2024-10-11 | 威里利生命科学有限责任公司 | 具有连接到颅骨安装包的整体式引线部件的刺激系统 |
| US11395923B2 (en) | 2018-11-16 | 2022-07-26 | Verily Life Sciences Llc | Branched proximal connectors for high density neural interfaces |
| US11376432B2 (en) | 2019-03-26 | 2022-07-05 | Twenty Twenty Therapeutics Llc | Non-invasive periocular device for dry-eye treatment |
| US11298537B2 (en) * | 2019-03-26 | 2022-04-12 | Twenty Twenty Therapeutics Llc | Non-invasive periocular device for dry-eye treatment and closed-loop methods for operating same |
| US12023498B2 (en) * | 2019-07-12 | 2024-07-02 | Biovisics Medical, Inc. | Ocular therapy modes and systems |
| US20250195888A1 (en) * | 2019-12-03 | 2025-06-19 | I-Lumen Scientific, Inc. | Systems, implantable devices and methods for vision related stimulation |
| CN111714793A (zh) * | 2020-05-21 | 2020-09-29 | 温州医科大学附属眼视光医院 | 一种高精度睑板腺诊疗仪 |
| US12310886B2 (en) * | 2020-08-03 | 2025-05-27 | Verily Life Sciences Llc | Ophthalmic devices, systems and methods for treating dry eye |
| DE102020121715B4 (de) * | 2020-08-19 | 2024-01-11 | Mane Biotech UG (haftungsbeschränkt) | Vorrichtung zur Stimulation des Haarwuchses |
| KR102451859B1 (ko) * | 2020-10-12 | 2022-10-11 | 고려대학교 산학협력단 | 3차원 망막 자극 디바이스 |
| CN112386795B (zh) * | 2020-11-18 | 2024-12-31 | 北京大学人民医院 | 一种植入式神经电刺激系统 |
| CN113058155B (zh) * | 2021-03-19 | 2024-09-03 | 中国科学院空天信息创新研究院 | 电引导治疗装置及方法 |
| WO2023076105A1 (en) | 2021-10-25 | 2023-05-04 | Twenty Twenty Therapeutics Llc | Fluid osmolarity sensing and associated systems, devices, and methods |
| US20250281747A1 (en) * | 2024-03-11 | 2025-09-11 | Verily Life Sciences Llc | System, method, and apparatus for underlid home-based meibomian gland disease treatment via resistive heating and magnetic-based mechanical stimulation |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7729758B2 (en) * | 2005-11-30 | 2010-06-01 | Boston Scientific Neuromodulation Corporation | Magnetically coupled microstimulators |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU577549B2 (en) * | 1983-09-14 | 1988-09-29 | Jacob Zabara | Neurocybernetic prothesis |
| WO1994000188A1 (en) * | 1992-06-24 | 1994-01-06 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
| JP2002519138A (ja) * | 1998-07-06 | 2002-07-02 | アドヴァンスド バイオニクス コーポレイション | 尿失禁治療処置のための移植可能な刺激器システムおよびその方法 |
| WO2000056393A1 (en) * | 1999-03-24 | 2000-09-28 | Second Sight, Llc | Retinal color prosthesis for color sight restoration |
| JP4781576B2 (ja) * | 2001-02-28 | 2011-09-28 | 株式会社ニデック | 眼内埋め込み型視覚刺激装置 |
| EP1372780A4 (en) * | 2001-03-30 | 2006-06-14 | Univ Case Western Reserve | SYSTEMS AND METHODS FOR SELECTIVELY STIMULATING PARTS LOCATED IN THE INTERNAL HATEYER NERVE ON OR NEAR THE NERF, OR FOR SELECTIVE STIMULATION OF NERVE RAMIFICATIONS IN QUESTION TO INDUCE SPECIFIC PHYSIOLOGICAL RESPONSES |
| US6735480B2 (en) * | 2001-06-29 | 2004-05-11 | Abbott Laboratories | Electro-acupuncture device with D-shaped stimulation electrodes |
| US6792312B2 (en) * | 2001-09-06 | 2004-09-14 | Medtronic, Inc. | Connector module having internal weld plates |
| EP1487536A4 (en) * | 2002-03-27 | 2009-12-02 | Cvrx Inc | DEVICES AND METHODS FOR CARDIOVASCULAR REFLEX CONTROL OF COUPLED ELECTRODES |
| US7142909B2 (en) * | 2002-04-11 | 2006-11-28 | Second Sight Medical Products, Inc. | Biocompatible bonding method and electronics package suitable for implantation |
| US20050165458A1 (en) * | 2002-05-09 | 2005-07-28 | Boveja Birinder R. | Method and system to provide therapy for depression using electroconvulsive therapy(ECT) and pulsed electrical stimulation to vagus nerve(s) |
| WO2003101535A1 (en) * | 2002-06-03 | 2003-12-11 | Med-El Elektromedizinische Geraete Gmbh | Implantable device with flexible interconnect to coil |
| JP4242195B2 (ja) * | 2003-04-10 | 2009-03-18 | 俊夫 大城 | 光治療器具 |
| US7571007B2 (en) * | 2004-04-12 | 2009-08-04 | Advanced Neuromodulation Systems, Inc. | Systems and methods for use in pulse generation |
| US7359751B1 (en) * | 2004-05-05 | 2008-04-15 | Advanced Neuromodulation Systems, Inc. | Clinician programmer for use with trial stimulator |
| CA2583404A1 (en) * | 2004-10-20 | 2006-04-27 | Boston Scientific Limited | Leadless cardiac stimulation systems |
| US7555345B2 (en) * | 2005-03-11 | 2009-06-30 | Medtronic, Inc. | Implantable neurostimulator device |
| US7702385B2 (en) * | 2005-11-16 | 2010-04-20 | Boston Scientific Neuromodulation Corporation | Electrode contact configurations for an implantable stimulator |
| US8606362B2 (en) * | 2005-07-08 | 2013-12-10 | Boston Scientific Neuromodulation Corporation | Current output architecture for an implantable stimulator device |
| JP2007044323A (ja) * | 2005-08-11 | 2007-02-22 | Nidek Co Ltd | 視覚再生補助装置 |
| US8005526B2 (en) * | 2005-08-31 | 2011-08-23 | The Regents Of The University Of Michigan | Biologically integrated electrode devices |
| US7444181B2 (en) * | 2005-12-14 | 2008-10-28 | Boston Scientific Neuromodulation Corporation | Techniques for sensing and adjusting a compliance voltage in an implantable stimulator device |
| US20070250135A1 (en) * | 2006-04-21 | 2007-10-25 | Bartz-Schmidt Karl U | Compound subretinal prostheses with extra-ocular parts and surgical technique therefore |
| US20070255333A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
| EP2068710A4 (en) * | 2006-09-27 | 2009-10-21 | Huntington Medical Res Inst | APPARATUS AND METHOD FOR TREATING AN OBSTRUCTIVE SLEEP APNEA |
| DE102006048819A1 (de) * | 2006-10-10 | 2008-04-17 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Vorrichtung mit einem Grundkörper |
| ES2559058T3 (es) * | 2006-10-18 | 2016-02-10 | Boston Scientific Neuromodulation Corp. | Dispositivo estimulador implantable de múltiples electrodos con un condensador único de desacoplamiento de trayectoria de corriente |
| WO2008101225A2 (en) * | 2007-02-16 | 2008-08-21 | Second Sight Medical Products, Inc. | Flexible circuit electrode array with wire or film support |
| US9592377B2 (en) * | 2007-07-27 | 2017-03-14 | Second Sight Medical Products, Inc. | Implantable device for the brain |
| US8805510B2 (en) * | 2007-08-02 | 2014-08-12 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods and systems for achieving a physiological response by pudendal nerve stimulation and blockade |
| EP2197536A1 (en) * | 2007-10-09 | 2010-06-23 | Imthera Medical, Inc. | System and method for neural stimulation |
| US8457757B2 (en) * | 2007-11-26 | 2013-06-04 | Micro Transponder, Inc. | Implantable transponder systems and methods |
| US8165694B2 (en) * | 2008-01-29 | 2012-04-24 | Boston Scientific Neuromodulation Corporation | Thermal management of implantable medical devices |
| DE102008002228A1 (de) * | 2008-06-05 | 2009-12-10 | Biotronik Crm Patent Ag | Langgestrecktes Implantat mit externer Energieeinkopplung |
| AU2009308359B2 (en) * | 2008-10-22 | 2014-11-13 | Advanced Neuromodulation Systems, Inc. | Method for processing electrodes for stimulation lead |
| WO2010069317A1 (en) * | 2008-12-19 | 2010-06-24 | Neurodan A/S | Bursts of electrical pulses in the treatment of pelvic disorders by electrical nerve stimulation |
| US8494641B2 (en) * | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| US9233254B2 (en) * | 2009-02-17 | 2016-01-12 | Boston Scientific Neuromodulation Corporation | Selectable boost converter and charge pump for compliance voltage generation in an implantable stimulator device |
| WO2010123704A2 (en) * | 2009-04-24 | 2010-10-28 | Medtronic, Inc. | Incontinence therapy |
| JP5578540B2 (ja) * | 2009-07-31 | 2014-08-27 | 株式会社ニデック | 視覚再生補助装置及び視覚再生補助装置の製造方法 |
| AU2009222439B2 (en) * | 2009-09-28 | 2011-07-21 | Cochlear Limited | Method and circuitry for measurement and control of stimulation current |
| WO2012068247A1 (en) * | 2010-11-16 | 2012-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
-
2012
- 2012-04-06 BR BR112013025671A patent/BR112013025671A2/pt not_active IP Right Cessation
- 2012-04-06 CN CN201610069087.7A patent/CN105727444B/zh not_active Expired - Fee Related
- 2012-04-06 EP EP12768458.7A patent/EP2694156B8/en not_active Not-in-force
- 2012-04-06 CN CN201280028006.9A patent/CN103747834B/zh not_active Expired - Fee Related
- 2012-04-06 RU RU2013149420/14A patent/RU2013149420A/ru not_active Application Discontinuation
- 2012-04-06 AU AU2012239966A patent/AU2012239966B2/en not_active Ceased
- 2012-04-06 WO PCT/US2012/032629 patent/WO2012139063A2/en not_active Ceased
- 2012-04-06 CA CA2832463A patent/CA2832463A1/en not_active Abandoned
- 2012-04-06 JP JP2014504050A patent/JP6169559B2/ja not_active Expired - Fee Related
- 2012-04-06 ES ES12768458.7T patent/ES2645204T3/es active Active
- 2012-04-06 EP EP17167504.4A patent/EP3263175B1/en not_active Not-in-force
-
2016
- 2016-02-26 AU AU2016201224A patent/AU2016201224B2/en not_active Ceased
-
2017
- 2017-06-28 JP JP2017125971A patent/JP6362734B2/ja not_active Expired - Fee Related
-
2018
- 2018-05-08 AU AU2018203202A patent/AU2018203202B2/en not_active Ceased
- 2018-06-26 JP JP2018120583A patent/JP6596124B2/ja not_active Expired - Fee Related
-
2019
- 2019-09-27 JP JP2019176723A patent/JP6746767B2/ja not_active Expired - Fee Related
-
2020
- 2020-08-05 JP JP2020132985A patent/JP2020192343A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7729758B2 (en) * | 2005-11-30 | 2010-06-01 | Boston Scientific Neuromodulation Corporation | Magnetically coupled microstimulators |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6362734B2 (ja) | 2018-07-25 |
| EP2694156B8 (en) | 2017-08-09 |
| EP3263175B1 (en) | 2021-11-24 |
| EP2694156A4 (en) | 2014-10-01 |
| EP2694156A2 (en) | 2014-02-12 |
| AU2018203202A1 (en) | 2018-05-31 |
| JP6169559B2 (ja) | 2017-07-26 |
| BR112013025671A2 (pt) | 2017-12-12 |
| RU2013149420A (ru) | 2015-05-20 |
| AU2012239966A1 (en) | 2013-05-02 |
| CN105727444A (zh) | 2016-07-06 |
| AU2016201224A1 (en) | 2016-03-24 |
| WO2012139063A3 (en) | 2012-12-27 |
| CA2832463A1 (en) | 2012-10-11 |
| EP2694156B1 (en) | 2017-06-14 |
| JP2020192343A (ja) | 2020-12-03 |
| JP2017164576A (ja) | 2017-09-21 |
| CN103747834B (zh) | 2016-03-02 |
| JP6596124B2 (ja) | 2019-10-23 |
| JP2014514070A (ja) | 2014-06-19 |
| JP2018196732A (ja) | 2018-12-13 |
| EP3263175A1 (en) | 2018-01-03 |
| AU2018203202B2 (en) | 2020-10-08 |
| JP6746767B2 (ja) | 2020-08-26 |
| JP2019213969A (ja) | 2019-12-19 |
| AU2012239966B2 (en) | 2015-11-26 |
| AU2016201224B2 (en) | 2018-02-08 |
| WO2012139063A2 (en) | 2012-10-11 |
| ES2645204T3 (es) | 2017-12-04 |
| CN103747834A (zh) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105727444B (zh) | 刺激装置 | |
| US10835748B2 (en) | Stimulation devices and methods | |
| US20250121197A1 (en) | Systems and methods for treatment of dry eye | |
| AU2017204067B2 (en) | Systems and methods for treatment of dry eye |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181009 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |